Oral Steroids vs. Parenteral Steroids for Stridor Management

Evidence on Steroid Administration for Stridor

Systemic steroid therapy significantly reduces both reintubation rates (5.8% vs. 17.0%) and postextubation stridor rates (10.8% vs. 31.9%) in patients at risk for airway complications 1, 2
Guidelines do not specifically differentiate between oral and parenteral routes for stridor management, suggesting similar efficacy 3, 4
For palliative care settings, nebulized corticosteroids (budesonide 500 μg 12 hourly) may be considered for stridor, though scientific evidence supporting this practice is limited 5, 4

For acute stridor, assess severity based on respiratory rate, heart rate, and ability to speak/feed 6, 7
In adults with severe symptoms (cannot complete sentences, respiratory rate >25/min, heart rate >110/min), provide oxygen plus oral steroids plus nebulized bronchodilators 6
In children with severe symptoms (cannot talk or feed, respiratory rate >50/min, heart rate >140/min), provide oxygen plus nebulized bronchodilators and consider oral steroids 6

A short course (5-7 days) of oral corticosteroids may be appropriate for very severe or intractable nasal symptoms or significant nasal polyposis 8
Single administration of parenteral corticosteroids is discouraged and recurrent administration is contraindicated due to greater potential for long-term corticosteroid side effects 8
Parenteral corticosteroid administration carries risks of prolonged adrenal suppression, local muscle atrophy, and fat necrosis 8

For most cases of stridor, oral steroids are preferred as first-line therapy due to similar efficacy to parenteral administration 8
Oral steroids have fewer complications related to administration 8
Reserve parenteral (IV) steroids for patients unable to take oral medications 6 or cases requiring immediate intervention due to severe airway compromise 3